Page 4 - P&g

P&G raises full-year profit, sales forecast due to sales surge amid Covid

(Reuters) - Procter & Gamble Co raised its full-year sales forecast on Tuesday as the consumer products giant benefited from a surge in demand for Bounty paper towels, Tide detergent and other cleaning supplies due to the COVID-19 pandemic.

Unilever, P&G push suppliers to rescue more than 300,000 seafarers

The letter, which was sent Wednesday to United Nations Secretary-General Antonio Guterres is the latest call to address a growing humanitarian crisis at sea brought about by the Covid-19 pandemic

P&G Health June-quarter net profit jumps 11% to Rs 49 cr despite low sales

Procter & Gamble Health, formerly known as Merck, on Wednesday reported a 10.8 per cent jump in June quarter net profit at Rs 48.9 crore. The profit growth came despite a fall in sales to Rs 200.3 crore due to the COVID-19 pandemic, as against Rs 224.9 crore in the April-June period of last year. "The company delivered a strong double-digit growth for four successive quarters up until the onset of the unprecedented COVID-19 pandemic. Despite initial impact on account of disruption in business operations, the company continues to demonstrate a resilient performance," its Managing Director Milind Thatte said. Protecting the health and safety of employees and partners, continuing to serve consumers, and support communities and relief efforts have been the company's priorities during the pandemic time, he added. In the 18 months to June, the company reported sales of Rs 1,329 crore. The sales figure had stood at Rs 818.2 crore in the calendar year 2018, it said in a statement. Profit

P&G Health declines 6% on profit booking post June quarter results

The board recommended a final dividend of Rs 230 per equity share (including a one-time special dividend of Rs 188 per equity share) for the financial year ended June 30, 2020.

Pricey valuation pull down P&G Hygiene stock despite strong Q4 results

A resilient portfolio and margin gains though can help earnings grow at 18-20 per cent annually over next two years

Aarti Drugs to Tata Comm: Earnings rise for 15 firms in Covid-19 economy

These companies reported an increase in revenue and/or profit before tax for the March quarter

Resilient portfolio may help P&G Hygiene recover faster than peers

However, high valuation may restrict immediate gains for the stock

Covid-19 lockdown: Mondelez, other FMCG giants indicate dent in business

In an investor call, Dirk Van de Put, Mondelez's global chairman and CEO said the firm went "absolutely blank" in the first phase of the lockdown, which began on March 25

Hindustan Unilever's valuation premium over peers hits record high

Trading at 77x, its trailing 12-month net profit against industry average of about 43x

Power Finance Corp profit down 13.6% in Dec quarter to Rs 2,395 crore

Total income rose to Rs 15,878 crore, from Rs 14,051 crore

P&G in tough spot as focus on revenue growth leads to compromise on profit

The gain was largely on account of the tax cuts announced in September. On the operating front, however, the key metrics look weak both on the revenue and margin fronts

Divergent India strategies: HUL goes aggressive, P&G more balanced

One set to be largest arm by FY27, the other slower in contrast

Procter & Gamble India sets up Rs 200-crore fund focused on climate

The new fund is in addition to its innovation sourcing fund that the company, the local unit of the world's largest consumer goods firm P&G, had launched last year

Wrongs you cannot right, just repent and regret

Strategic errors - acts of omission and commission - have hurt many companies

P&G Hygiene and Health Care Q3 net down 5% to Rs 124 cr on cost inflation

FMCG major Procter & Gamble Hygiene and Health Care Ltd (PGHHCL) Thursday reported a 5.42 per cent decline in profit after tax (PAT) to Rs 124.12 crore in the third quarter ended December 2018. It had posted a PAT of Rs 131.24 crore in the corresponding period last fiscal, PGHHCL said in a regulatory filing. Total income during the quarter stood at Rs 829.73 crore as compared with Rs 711.25 crore in the year-ago quarter, a rise of 16.65 per cent. PGHHCL said its profit was impacted due to cost inflation and strategic investments on brand building initiatives to accelerate growth. Commenting on the quarterly performance, PGHHCL Managing Director Madhusudan Gopalan said: "We have delivered strong double-digit (sales) growth for the second consecutive quarter this year driven by robust volume growth, category development and execution excellence." He said the company would continue to focus on raising the bar on superiority of products, packaging, go-to-market and communication, ...

P&G Home turns profitable after 4 years; sales still lower than in FY14

Group seems to have taken eye off India in global strategy

P&G India net up for 2nd straight quarter, Q2 sales growth in double digits

For the year ended June 30, 2018, P&G Hygiene & Healthcare reported a turnover of Rs 24.6 billion, a growth of 6 per cent over the previous year

CCI approves P&G's acquisition of 51.80% stake in drug firm Merck Ltd

The Competition Commission has approved Procter & Gamble's acquisition of 51.80 per cent stake in drug firm Merck Ltd, which is listed on the Indian bourses. The acquisition of 51.80 per cent stake in Merck Ltd by P&G for nearly Rs 1,290 crore is part of a global deal under which the latter is taking over German firm Merck KGaA's international consumer health business. The global deal is for about 3.4 billion euro in cash. In a tweet today, the Competition Commission of India (CCI) said it has approved acquisition of 51.80 per cent stake by P&G in consumer health business of Merck Ltd. The stake acquisition will be through Procter & Gamble Overseas India BV, an investment holding company held ultimately by P&G. According to the notice submitted to the CCI, P&G had proposed to acquire the consumer health business of Merck KGaA globally, pursuant to a sale and purchase agreement dated April 19, 2018 (Global SAPA). As part of the agreement, P&G had also ...

Procter & Gamble upbeat about Indian market as biz grows in double-digits

In India, P&G operates through two listed and one unlisted company, which together delivered a top line of Rs 90 billion for the financial year 2016-17

Procter & Gamble sees double-digit sales growth in Indian market in Q1

P&G's archrival Unilever had also said that it had delivered strong Q1 sales growth in emerging markets, led by an uptick in volume growth